Dario selected to provide integrated approach to improve employee cardiometabolic health – including support for those taking a GLP-1 medication – musculoskeletal and behavioral health

NEW YORK, April 2, 2024– DarioHealth Corp. (Nasdaq: DRIO) (“Dario” or the “Company”), a leader in the global digital health market, announced today two new contracts to provide integrated chronic condition management solutions for two national employers beginning in the second quarter of 2024.

The first employer, a global private investment group, selected Dario’s cardiometabolic suite to help improve outcomes for employees with cardiometabolic health conditions, including diabetes, pre-diabetes, hypertension and weight management needs, including support for individuals taking a GLP-1.

The second employer, a national professional services company, selected Dario’s full suite of solutions to deliver personalized support for employees living with cardiometabolic health conditions and commonly co-occurring musculoskeletal and behavioral health needs.

Dario combines intelligent technologies with billions of data insights gathered from a decade of consumer engagement to deliver highly personalized experiences that keep members engaged over time for optimal results. Employees enrolled in Dario’s cardiometabolic solution who are taking a GLP-1 medication will also have access to a tailored experience to support long-term behavior change.

“The need for an integrated approach to address the most common and chronic health needs continues to drive demand for Dario’s multi-chronic solutions. Our ability to ensure each employee receives proven, highly personalized support – especially with the growing use of GLP-1s – is the reason we believe that more companies like our two new employer clients are selecting Dario and we are excited to deliver the high-value support they require,” said Rick Anderson, President of Dario.


About DarioHealth Corp.

DarioHealth Corp. (Nasdaq: DRIO) is a leading digital health company revolutionizing how people with chronic conditions manage their health through a user-centric, multi-chronic condition digital therapeutics platform. Dario’s platform and suite of solutions deliver personalized and dynamic interventions driven by data analytics and one-on-one coaching for diabetes, hypertension, weight management, musculoskeletal pain and behavioral health.

Dario’s user-centric platform offers people continuous and customized care for their health, disrupting the traditional episodic approach to healthcare. This approach empowers people to holistically adapt their lifestyles for sustainable behavior change, driving exceptional user satisfaction, retention and results and making the right thing to do the easy thing to do.

Dario provides its highly user-rated solutions globally to health plans and other payers, self-insured employers, providers of care and consumers. To learn more about Dario and its digital health solutions, or for more information, visit https://www.dariohealth.com